Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
405 INR | +1.76% | -4.10% | -0.09% |
04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.09% | 1.15B | |
+29.52% | 684B | |
+30.07% | 568B | |
-4.01% | 361B | |
+18.28% | 329B | |
+4.61% | 284B | |
+16.02% | 240B | |
+9.53% | 208B | |
-6.79% | 200B | |
+8.25% | 166B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Transcript : Granules India Limited, Q3 2024 Earnings Call, Jan 23, 2024